O'Shaughnessy Asset Management, LLC Allakos Inc. Transaction History

O'Shaughnessy Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$8.55 - $111.89 $5,762 - $75,413	-674 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$76.53 - $110.43 $55,101 - $79,509	-720 Reduced 51.65%	674 $71,000
Q2 2021 Aug 09, 2021	SELL	$85.37 - $114.1 $10,329 - $13,806	-121 Reduced 7.99%	1,394 $119,000
Q1 2021 May 14, 2021	BUY	$109.73 - $153.66 $69,129 - $96,805	630 Added 71.19%	1,515 $174,000
Q4 2020 Feb 11, 2021	BUY	$79.58 - $152.45 $70,428 - $134,918	885 New	885 $124,000

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $91.5M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.